MHC class I expression in sarcoma tumors.
Histological subtype | Case no. | MHC class I expression | |
W6/32 a | Interpretation b | ||
Gastrointestinal stromal tumor | 1 | C1 | + |
2 | C2 | + | |
3 | A1 | - | |
4 | B1 | + | |
5 | C2 | + | |
Synovial sarcoma | 1 | A0 | - |
Uterine leiomyosarcoma | 1 | C2 | + |
3 | C2 | + | |
4 | C2 | + | |
Leiomyosarcoma | 1 | A0 | - |
2 | A0 | - | |
3 | C2 | + | |
4 | C2 | + | |
5 | C2 | + | |
6 | C2 | + | |
Angiosarcoma | 1 | C2 | + |
3 | C2 | + | |
Malignant fibrous histiocytoma | 1 | C2 | + |
2 | A0 | - | |
4 | C2 | + | |
5 | B2 | + | |
Liposarcoma | 1 | C2 | + |
2 | A0 | - | |
5 | C2 | + | |
6 | A2 | + | |
Chondrosarcoma | 1 | C2 | + |
aW6/32 scoring based on intensity (score from 0 to 3) and percentage of positive cells (A: <25% positive cells, B: 25-75% positive cells, C: >75% positive cells). bCases were considered negative if the immunohistochemical staining had a score of 0 to 1 in less than or equal to 25% tumor cells (A0 or A1). All other cases were considered positive.